Search results :

Penciclovir

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: D06BB06, J05AB13

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Headache Headache postmarketing, 8.5% - 39.3% 5.4% - 42.9% x x x x x x x x x x x x x x x x
Diarrhoea Diarrhoea 1.6% - 9% 0.8% - 9.5% x x x x x x x x x x
Neutropenia Neutropenia 3.2% 1.5% x x x x x x x x x x
Nausea Nausea 2.2% - 12.5% 3.6% - 11.6% x x x x x x x x x x
Dysmenorrhoea Dysmenorrhoea 0% - 7.6% 0% - 6.3% x x x x x x x x x x
Asthenia Fatigue 0.6% - 4.8% 0% - 3.4% x x x x x x x x x x
Fatigue Fatigue 0.6% - 4.8% 0% - 3.4% x x x x x x x x x x
Leukopenia Leukopenia 1.3% 0.9% x x x x x x x x x x
Vomiting Vomiting 0.7% - 4.8% 0% - 3.4% x x x x x x x x x x
Hypoaesthesia Hypoaesthesia 0.9% 1.4% x x x x x
Application site reaction Application site reaction postmarketing, 1.3% 1.8% x x
Flatulence Flatulence 0.2% - 4.8% 0% - 1.6% x x x x x x x x x x
Migraine Migraine 0.2% - 3.1% 0% - 0.7% x x x x x x x x x x
Abdominal pain Abdominal pain 0% - 7.9% 0.4% - 7.9% x x x x x x x x x x
Gastrointestinal pain Abdominal pain 0% - 7.9% 0.4% - 7.9% x x x x x x x x x x
Dysgeusia Dysgeusia 0.2% 0.3% x x x x
Anaemia Anaemia 0.1% 0% x x x x x x x x x x
Angioedema Angioedema postmarketing x x x x x x x x x
Mental disorder Mental disorder postmarketing x x x x x x x x x x
Confusional state Confusional state postmarketing x x x x x x x x x x
Feeling abnormal Confusional state postmarketing x x x x x x x x x x
Delirium Delirium postmarketing x x x x x x x x x x
Dizziness Dizziness postmarketing x x x x x x x x x x
Toxic epidermal necrolysis Toxic epidermal necrolysis postmarketing x x x x x x x x x x
Erythema multiforme Erythema multiforme postmarketing x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x
Hallucination Hallucination postmarketing x x x x x x x x x x
Cardiac disorder Cardiac disorder postmarketing x x x x x x
Oral herpes Herpes labialis postmarketing x x x x
Jaundice cholestatic Jaundice cholestatic postmarketing x x x x x x x x x x
Nervous system disorder Nervous system disorder postmarketing x x x x x x x x x x
Pain Pain postmarketing, 0% 0.1% x x x x x x
Palpitations Palpitations postmarketing x x x x x x
Paraesthesia Paraesthesia postmarketing, 0% - 2.6% 0% x x x x x x x x x x x x x x x x
Pruritus Pruritus postmarketing, 0% - 3.7% 0% - 2.7% x x x x x x x x x x x x x x x x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x x x x x x x x x x
Thrombocytopenia Thrombocytopenia postmarketing x x x x x x x x x x
Urticaria Urticaria postmarketing x x x x x x x x x x x x x x x x
Liver function test abnormal Liver function test abnormal postmarketing x x x x x x x x x x
Skin discolouration Skin discolouration postmarketing x x x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x x x x x
Disorientation Disorientation postmarketing x x x x x x x x x x
Rash erythematous Rash erythematous postmarketing x x x x
Therapeutic response decreased Therapeutic response decreased postmarketing x x x x x x
Pharyngeal oedema Pharyngeal oedema postmarketing x x x x x x x x x x x x x x x x
Hepatobiliary disease Hepatobiliary disease postmarketing x x x x x x x x x x
Local swelling Local swelling postmarketing x x x x x x
Parosmia Parosmia postmarketing x x x x x x
Somnolence Somnolence postmarketing x x x x x x x x x x
Leukocytoclastic vasculitis Leukocytoclastic vasculitis postmarketing x x x x x x
Dermatitis Rash 0% - 3.3% 0% - 1.6% x x x x x x x x x x x x x x
Rash Rash 0% - 3.3% 0% - 1.6% x x x x x x x x x x x x x x
Hypersensitivity Hypersensitivity 0% 0.1% x x x
Renal failure acute Renal failure acute x x x x x x x x x x
Erythema Erythema x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

penciclovir / Denavir

Side effects:14
Source:FDA

PENCICLOVIR

Side effects:14
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:15
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:16
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:17
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:17
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:34
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:36
Source:FDA Structured Product Label

Penciclovir

Side effects:36
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:36
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:39
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:39
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:39
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:39
Source:FDA Structured Product Label

PENCICLOVIR

Side effects:39
Source:FDA Structured Product Label

penciclovir

Side effects:39
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label